Kwang Dong Pharmaceutical Co., Ltd. (KRX:009290)
South Korea · Delayed Price · Currency is KRW 8,430.00
-50.00 (-0.59%)
At close: Apr 16, 2026
Kwang Dong Pharmaceutical Revenue
In the year 2025, Kwang Dong Pharmaceutical had annual revenue of 1.66T KRW with 1.15% growth. Kwang Dong Pharmaceutical had revenue of 412.10B in the quarter ending December 31, 2025, with 5.44% growth.
Revenue
1.66T
Revenue Growth
+1.15%
P/S Ratio
0.19
Revenue / Employee
1.63B
Employees
1,021
Market Cap
310.87B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.66T | 18.79B | 1.15% |
| Dec 31, 2024 | 1.64T | 126.26B | 8.34% |
| Dec 31, 2023 | 1.51T | 82.91B | 5.79% |
| Dec 31, 2022 | 1.43T | 93.36B | 6.98% |
| Dec 31, 2021 | 1.34T | 94.41B | 7.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Daesang Holdings | 5.63T |
| Sajodaerim | 3.50T |
| EASY HOLDINGS | 3.39T |
| Pulmuone Corporate | 3.38T |
| SPC Samlip | 3.37T |
| Samyang | 2.56T |
| Maeil Dairies | 1.84T |
| Daehan Flour Mills Co.,Ltd | 1.38T |